Senator Investment Group LP Avrobio, Inc. Transaction History

Senator Investment Group LP

  • $2.03 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 17, 2021
SELL
$10.54 - $19.3 $5.8 Million - $10.6 Million
-550,000 Closed
0 $0
Q4 2020

Feb 16, 2021
BUY
$12.79 - $17.1 $639,500 - $855,000
50,000 Added 10.0%
550,000 $7.67 Million
Q2 2020

Aug 13, 2020
BUY
$12.19 - $22.96 $6.1 Million - $11.5 Million
500,000 New
500,000 $8.73 Million

Others Institutions Holding AVRO

# of Institutions
1
Shares Held
559K
Call Options Held
0
Put Options Held
0
View Full List

About AVROBIO, Inc.

AVRO Quotes by TradingView
  • Ticker AVRO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,773,900
  • Description
  • AVROBIO, Inc., a clinical-stage gene therapy company, develops ex vivo lentiviral-based gene therapies to treat rare diseases following a single dose worldwide. Its gene therapies employ hematopoietic stem cells that are collected from patients and modified with a lentiviral vector to insert functional copies of the gene that is defective in the...
More about AVRO
Track This Portfolio

Track Senator Investment Group LP Portfolio

Follow Senator Investment Group LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Senator Investment Group LP, based on Form 13F filings with the SEC.

News

Stay updated on Senator Investment Group LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email